Glycoside Hydrolase Inhibitors
"Glycoside Hydrolase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES.
| Descriptor ID |
D065089
|
| MeSH Number(s) |
D27.505.519.389.320 D27.505.696.422.249
|
| Concept/Terms |
Pancreatic alpha-Amylase Inhibitors- Pancreatic alpha-Amylase Inhibitors
- Inhibitors, Pancreatic alpha-Amylase
- Pancreatic alpha Amylase Inhibitors
- alpha-Amylase Inhibitors, Pancreatic
- alpha Amylase Inhibitors, Pancreatic
Intestinal alpha-Amylase Inhibitors- Intestinal alpha-Amylase Inhibitors
- Inhibitors, Intestinal alpha-Amylase
- Intestinal alpha Amylase Inhibitors
- alpha-Amylase Inhibitors, Intestinal
|
Below are MeSH descriptors whose meaning is more general than "Glycoside Hydrolase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Glycoside Hydrolase Inhibitors".
This graph shows the total number of publications written about "Glycoside Hydrolase Inhibitors" by people in this website by year, and whether "Glycoside Hydrolase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 1 | 3 |
| 2018 | 8 | 1 | 9 |
| 2019 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Glycoside Hydrolase Inhibitors" by people in Profiles.
-
The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication. Glycobiology. 2021 05 03; 31(4):378-384.
-
Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2. Viruses. 2021 04 30; 13(5).
-
How glycobiology can help us treat and beat the COVID-19 pandemic. J Biol Chem. 2021 Jan-Jun; 296:100375.
-
a-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19. Biochem Soc Trans. 2020 Jun 30; 48(3):1287-1295.
-
New triazinoindole bearing thiazole/oxazole analogues: Synthesis, a-amylase inhibitory potential and molecular docking study. Bioorg Chem. 2019 11; 92:103284.
-
Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro a-glucosidase inhibition, kinetic, and docking studies. Bioorg Chem. 2019 11; 92:103206.
-
Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An Update. Curr Pharm Des. 2019; 25(23):2510-2525.
-
Pyrano[3,2-c]quinoline Derivatives as New Class of a-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study. Med Chem. 2019; 15(1):8-16.
-
Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro a-glucosidase inhibition, kinetic, and docking study. Bioorg Chem. 2019 03; 83:161-169.
-
Interaction of antidiabetic a-glucosidase inhibitors and gut bacteria a-glucosidase. Protein Sci. 2018 08; 27(8):1498-1508.